Damodaran Narayanan, M.D., Ph.D.


Joined Clinical Pathology Associates: 2022

Primary Service Location:

Rotating Pathologist (no primary location)

Board Certifications:

  • Board Certified in Hematopathology (2023)
  • Board Certified in Anatomic and Clinical Pathology (2022)

Areas of Interest:

  • Anatomic and Clinical Pathology
  • Hematopathology


  • Brigham and Women’s Hospital/Harvard Medical School (BWH/HMS)


  • Brigham and Women’s Hospital / Dana-Farber Cancer Institute, Boston, MA
  • University of Wisconsin Hospital and Clinics, Madison, WI.

Medical School:

  • Madras Medical College and Government General Hospital
    The Tamil Nadu Dr. M.G.R. Medical University, Chennai, India

Post Graduate Education:

  • Department of Physiology
    University of Tennessee Health Science Center, Memphis, TN.

Selected Publications:

  • TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML. Weinberg OK, Siddon A, Madanat YF, Gagan J, Arber DA, Dal Cin P, Narayanan D, Ouseph MM, Kurzer JH, Hasserjian RP. Blood Adv. 2022 May 10;6(9):2847-2853. https://doi.org/10.1182/bloodadvances.2021006239. PMID: 35073573
  • Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AML. Narayanan D, Pozdnyakova O, Hasserjian RP, Patel SS, Weinberg OK. Blood Adv. 2021 Jun 8;5(11):2539-2549. https://doi.org/10.1182/bloodadvances.2021004250. PMID: 34100902
  • Marked dysgranulopoiesis mimicking disseminated histoplasmosis. Narayanan D, Pozdnyakova O. Blood. 2020 Dec 10;136(24):2838. https://doi.org/10.1182/blood.2020009047. PMID: 33301038.
  • How I investigate acute myeloid leukemia. Narayanan D and Weinberg OK. Int J Lab Hematol. 2020 Feb;42(1):3-15. https://doi.org/10.1111/ijlh.13135. PMID: 31820579